Wix.com Ltd. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Wix.com Ltd. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2024
Revenue	290	426	604	758	984	1,270	1,388	1,562	1,761	1,993
Cost of revenue	45.3	69.4	127	195	313	489	526	513	565	636
Gross profit	245	356	477	563	671	781	861	1,049	1,196	1,357
Research and development	105	154	199	251	320	425	483	481	495	646
Selling and marketing	157	204	249	308	438	512	493	400	425	514
General and administrative	27	48.2	59.3	85.9	112	170	171	160	175	195
Operating expenses	289	406	507	644	870	1,107	1,147	1,074	1,096	1,355
Operating income	-44	-50	-30.6	-81.6	-199	-326	-285	-24.4	100	1.75
Interest income	0.85	1.18	9.61	19.8	16.4	10.5	19.4	45.2	42	48.9
Other non-operating income	0.25	-5.02	-2.79	-3.62	47.1	272	-184	62.5	51.8	-5.02
Pre-tax income	-43.8	-55	-33.9	-85.2	-152	-53	-468	37.8	152	1.09
Income tax	3.11	1.32	3.21	2.6	15	64.2	-43	4.7	13.6	-51
Net income	-46.9	-56.3	-37.1	-87.7	-167	-117	-425	33.1	138	50.6
EBITDA	-39.5	-44.4	-21.9	-69.5	-184	-312	-269	-3.89	125	26.2
EPS, basic	-1.12	-1.24	-0.77	-1.74	-3.07	-2.06	-7.33	0.58	2.49	0.91
EPS, diluted	-1.12	-1.24	-0.77	-1.74	-3.07	-2.06	-7.33	0.57	2.36	0.88
Shares, basic (weighted)	42	45.6	48	50.5	54,425	57	58	56.8	55.6	55.6
Shares, diluted (weighted)	8.41	8.21	7.68	7.45	54,425	57	58	58.4	60	57.7

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2024
Cash and equivalents	93.1	85.2	331	268	169	451	245	610	661	311
Short-term investments	55.5	115	350	164	290	457	292	141	339	484
Receivables	8.28	11.4	13.5	17	23.7	30.4	42.1	57.4	44.7	41.5
Other current assets	3.4	1.59	2.19	5.73	12.2	8.02	9.31	6.37	12.6	18.3
Total current assets	198	265	730	764	1,101	1,390	1,148	1,070	1,280	1,324
Property, plant and equipment	8.75	16.2	21.9	31.7	35.9	50.4	109	137	128	114
Lease right-of-use assets				79.2	88.4	101	201	421	400	398
Goodwill	1.74	17.8	17.8	17.8	24.2	49.3	49.3	49.3	49.3	135
Intangible assets	3.72	27.3	24.4	19.8	19.3	40.2	34	28	22.1	31.8
Long-term investments			47.2	177	537	387	195	64.8	6.14	474
Other non-current assets									33.2	513
Total assets	215	330	845	1,100	1,894	2,060	1,758	1,804	1,913	2,611
Accounts payable	20.7	34.2	45.6	37.7	79.9	115	96.1	38.3	47.1	74.8
Accrued liabilities	16.9	33.2	32.6	36.2	19	32.8	30.5	36.7	31.9	53.1
Deferred revenue	147	202	227	289	410	484	529	593	661	737
Total current liabilities	207	302	340	444	631	774	1,190	789	1,515	1,113
Lease liabilities				64.2	74.2	81.8	173	402	369	418
Other non-current liabilities		1.22	1.22	1.22	0	2.27	6.09	7.7	16	200
Total liabilities	217	319	692	892	1,606	1,914	2,022	1,859	1,992	2,977
Paid-in capital	241	311	472	611	862	995	1,275	1,540	1,841	2,067
Retained earnings	-243	-300	-318	-405	-584	-648	-1,073	-1,040	-902	-851
Treasury stock					0	-200	-432	-559	-1,025	-1,600
Other comprehensive income	-0.39	-0.29	-1.69	1.36	9.41	-1.06	-33.5	4.19	7.24	17.5
Shareholders' equity	-2.47	11.3	141	195	287	146	-263	-54.5	-78.8	-366
Total equity	-2.47	11.3	141	195	287	146	-263	-54.5	-78.8	-366
Total liabilities and equity	215	330	845	1,100	1,894	2,060	1,758	1,804	1,913	2,611
Shares outstanding	44.3	46.5	49.3	51.5	56,028	57.3	56.3	57.2	56.1

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2024
Net income	-46.9	-56.3	-37.1	-87.7	-167	-117	-425	33.1	138	50.6
Depreciation and amortization	4.54	5.65	8.72	12.1	14.6	13.9	16.6	20.5	25.2	24.5
Stock-based compensation	28	47.7	72.3	109	147	221	237	225	241	237
Deferred income tax	-0.32	-2.72	-0.98	-0.71	15.5	53.6	-57.9	-6.02	0.95	-97.2
Change in receivables	-1.82	-1.94	-2.13	-3.46	-6.46	-6.25	-11.7	-15.3	12.7	3.22
Cash from operations	40.6	83.1	116	150	148	65.7	37.2	248	497	583
Capital expenditures	-4.42	-11.6	-13.7	-21.4	-18.4
Acquisitions		-33.1		0	-6.63	-42.7	0	0	0	-23.9
Purchases of investments	-23.7	-33.2	-1.25	-403	-764	-29.4	-203	-6.73
Sales and maturities of investments	0.98	0.25	21.1	133	277	312	290	251
Cash from investing	-8.39	-115	-288	-244	-800	377	-54.7	567	-35.5	-902
Stock issued	21.7	24.2	32.9	31.5	39.6	39.9	42.7	39.7	59.6	54.8
Share buybacks				0	0	-200	-232	-127	-466	-575
Cash from financing	21.7	24	418	31.5	553	-160	-189	-450	-407	-43
Exchange rate effect							0	0	-3.91	18.2
Net change in cash	53.8	-7.83	246	-63	-99.2	282	-207	365	51.3	-344
Free cash flow	36.2	71.4	102	128	130
Income taxes paid	2.64	4.42	3.67	3.11	5.81	6.52	11.4	12.4	11.3	3.56

Key metrics

Worked out from the statements above. Latest values use fiscal 2024. Valuation uses the share price of $73.79 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	68.1%	Gross profit / revenue.
Operating margin	0.1%	Operating income / revenue.
EBITDA margin	1.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	0.1%	Pre-tax income / revenue.
Net margin	2.5%	Net income / revenue.
Operating cash flow margin	29.2%	Cash from operations / revenue.
Effective tax rate	-4,688.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)	2.2%	Net income / average total assets.
R&D / revenue	32.4%	Research and development expense / revenue.
Stock-based pay / revenue	11.9%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	1.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	13.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	12.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	15.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	13.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	16.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	15.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-98.3%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-79.1%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	-63.4%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-62.7%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	17.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	150.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	31.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	36.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	14.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-3.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-74.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.19x	Current assets / current liabilities.
Quick ratio	0.75x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.71x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	114.0%	Total liabilities / total assets.
Working capital	$211.4M	Current assets - current liabilities.
Goodwill and intangibles / assets	6.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$532.8M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.88x	Revenue / average total assets.
Fixed asset turnover	16.4x	Revenue / average property, plant and equipment.
Receivables turnover	46.2x	Revenue / average receivables.
Days sales outstanding	8 days	365 x average receivables / revenue.
Days payables	35 days	365 x average accounts payable / cost of revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.88	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$0.91	Net income per basic share, as reported (split-adjusted).
Revenue per share	$34.53	Revenue / diluted weighted shares.
Operating cash flow per share	$10.10	Cash from operations / diluted weighted shares.
Book value per share	-$6.34	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$9.23	Tangible book value / shares outstanding.
Cash per share	$13.78	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$4.06B	Share price x shares outstanding.
Enterprise value	$3.27B	Market cap + total debt - cash - short-term investments.
P/E	80.2x	Market cap / net income. Only when net income is positive.
P/S	2.04x	Market cap / revenue.
P/OCF	6.97x	Market cap / cash from operations, when positive.
EV/Sales	1.64x	Enterprise value / revenue.
EV/EBIT	1,865x	Enterprise value / operating income, when both are positive.
EV/EBITDA	124x	Enterprise value / EBITDA, when both are positive.
Earnings yield	1.2%	Net income / market cap (the inverse of P/E).
Shareholder yield	14.2%	(Dividends paid + share buybacks) / market cap.

What was Wix.com Ltd.'s revenue in fiscal 2024?

Wix.com Ltd. reported revenue of $1.99B for fiscal 2024, 13.2% higher than the year before.

Was Wix.com Ltd. profitable in fiscal 2024?

Yes. Net income was $50.6M, a net margin of 2.5%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Wix.com Ltd.